Prognostic utility of natriuretic peptides and incremental value of the HFA-ICOS risk score in patients with multiple myeloma
In patients with MM, baseline BNP levels demonstrated fair discrimination for predicting heart failure and all-cause mortality, and equivalent predictive performance compared with the HFA-ICOS risk score, which supports the use of BNP levels as an efficient tool for risk stratification in patients with MM.